Form 8-K - Current report:
SEC Accession No. 0000920148-24-000111
Filing Date
2024-10-10
Accepted
2024-10-10 06:58:48
Documents
15
Period of Report
2024-10-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lh-20241009.htm   iXBRL 8-K 25896
2 EX-99.1 formpr101024ex991dividenda.htm EX-99.1 4606
6 lc2020logov2a.gif GRAPHIC 4887
  Complete submission text file 0000920148-24-000111.txt   163315

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lh-20241009.xsd EX-101.SCH 2173
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lh-20241009_lab.xml EX-101.LAB 22141
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lh-20241009_pre.xml EX-101.PRE 12614
18 EXTRACTED XBRL INSTANCE DOCUMENT lh-20241009_htm.xml XML 2798
Mailing Address 358 S MAIN ST BURLINGTON NC 27215
Business Address 358 S MAIN ST BURLINGTON NC 27215 3362291127
LABCORP HOLDINGS INC. (Filer) CIK: 0000920148 (see all company filings)

EIN.: 992588107 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11353 | Film No.: 241363799
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)